Tejara Capital LTD has filed its 13F form on May 13, 2025 for Q1 2025 where it was disclosed a total value porftolio of $259 Billion distributed in 75 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcutis Biotherapeutics, Inc. with a value of $13.2B, Heron Therapeutics, Inc. with a value of $10.1B, Roivant Sciences Ltd. with a value of $8.94B, Nov Inc. with a value of $8.78B, and Noble Corp PLC with a value of $8.15B.

Examining the 13F form we can see an increase of $107B in the current position value, from $153B to 259B.

Tejara Capital LTD is based out at London, X0

Below you can find more details about Tejara Capital LTD portfolio as well as his latest detailed transactions.

Portfolio value $259 Billion
Healthcare: $74.2 Billion
Energy: $72.1 Billion
ETFs: $56.3 Billion
Technology: $12.1 Billion
Utilities: $7.65 Billion
Basic Materials: $7.03 Billion
Industrials: $1.04 Billion
Communication Services: $805 Million
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 75
  • Current Value $259 Billion
  • Prior Value $153 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 13, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 30 stocks
  • Additional Purchases 27 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.